Neovascularization of bone marrow in patients with diffuse multiple myeloma: A correlative study of magnetic resonance imaging and histopathologic findings

Cancer

Volumn 101, Issue 11, 2004, Pages 2599-2604

  Baur, Andrea ^a   Bartl, Reiner ^a   Pellengahr, Christoph ^a   Baltin, Vivian ^a   Reiser, Maximilian ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiogenesis; Bone marrow; Gadolinium; Magnetic resonance imaging; Microvessel density; Multiple myeloma

Indexed keywords

CD34 ANTIGEN; GADOLINIUM PENTETATE;

ADIPOCYTE; ADULT; AGED; ARTICLE; BONE MARROW; CANCER STAGING; CELL INFILTRATION; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROCIRCULATION; MULTIPLE MYELOMA; NEOVASCULARIZATION (PATHOLOGY); NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL; PRIORITY JOURNAL; SPINE SCINTISCANNING;

ADIPOCYTES; ADULT; AGED; BONE MARROW NEOPLASMS; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROCIRCULATION; MIDDLE AGED; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; SENSITIVITY AND SPECIFICITY; SPINE;

EID: 8844277549     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20697     Document Type: Article

References (23)

1. Acenero MJ, Gonzales JF, Gallego GM, Ballesteros PA. Vascular enumeration as a significant prognosticator for invasive breast carcinoma. J Clin Oncol. 1998;16:1684-1688.
2. Chaudhary R, Bromley M, Clarke NW, et al. Prognostic relevance of microvessel density in cancer of the urinary bladder. Anticancer Res. 1999;19:3479-3484.
3. Gallego GM, Acenero MJ, Sanz-Ortega J, Aljama A. Vascular enumeration as a prognosticator for colorectal carcinoma. Eur J Cancer. 2000;36:55-60.
4. Hlatky L, Hahnfeldt P, Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 2002;94:883-893.
5. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood. 2000;96:2240-2245.
6. Kini AR, Kay NE, Peterson LC. Increased bone marrow angiogenesis in B cell chronic lymphocytic leukemia. Leukemia. 2000;14:1414-1418.
7. Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol. 1994;87:503-508.
8. Rajkumar SV, Leong T, Roche PC, et al. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res. 2000;6:3111-3116.
9. Rajkumar AV, Mesa RA, Fonseca R, et al. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma and primary amyloidosis. Clin Cancer Res. 2002;8:2210-2216.
10. Sezer O, Niemöller K, Eucker J, et al. Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma. Ann Hematol 2000;79:574-577.
11. Pruneri G, Ponzoni M, Ferreri AJ, et al. Microvessel density, a surrogate marker of angiogenesis, is significantly related to survival in multiple myeloma patients. Br J Haematol. 2002;118:817-820.
12. Niemöller K, Jakob C, Heider U, et al. Bone marrow angiogenesis and its correlation with other disease characteristics in multiple myeloma in Stage I versus Stage II-III. J Cancer Res Clin Oncol. 2003;129:234-238.
13. Vacca A, Loreto M, Ribatti D, et al. Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am J Hematol. 1995;50:9-14.
14. Vacca A, Ribatti D, Presta M, et al. Bone marrow neovascularization, plasma cell angiogenetic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood. 1999;93:3064-3073.
15. Staebler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser M. Contrast enhancement and quantitative signal analysis in MRI of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. AJR Am J Roentgenol. 1996;167:1029-1036.
16. Daffner RH, Lupetin AR, Dash N, Deeb ZL, Sefcek RJ, Schapiro RL. MRI in the detection of malignant infiltration of bone marrow. AJR Am J Roentgenol. 1986;146:353-358.
17. Moulopoulos LA, Varma DG, Dimopoulos MA, et al. Multiple myeloma: spinal MR imaging in patients with untreated newly diagnosed disease. Radiology. 1992;185:833-840.
18. Baur A, Stäbler A, Nagel D, et al. MRI as a supplement for the clinical staging system of Durie and Salmon? Cancer. 2002;15:1334-1345.
19. Mariette X, Zagdanski AM, Guermazi A, et al. Prognostic value of vertebral lesions detected by MRI in patients with Stage I multiple myeloma. Br J Haematol. 1999;104:723-729.
20. Moulopoulos LA, Maris TG, Papanikolaou N, Panagi G, Vlahos L, Dimopoulos MA. Detection of malignant bone marrow involvement with dynamic contrast enhanced magnetic resonance imaging. Ann Oncol. 2003;14:152-158.
21. Rahmouni A, Montazel JL, Divine M, et al. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging. Radiology. 2003;229:710-717.
22. Sezer O, Niemöller K, Kaufmann O, et al. Decrease of bone marrow angiogenesis in myeloma patients achieving a remission after chemotherapy. Eur J Haematol. 2001;66:238-244.
23. Rajkumar SV, Fonseca R, Witzig TE, Gertz MA, Greipp PR. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma. Leukemia. 1999;13:469-472.